Sue Aspley

1.7k total citations
41 papers, 1.3k citations indexed

About

Sue Aspley is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sue Aspley has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Pharmacology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sue Aspley's work include Respiratory and Cough-Related Research (13 papers), Streptococcal Infections and Treatments (10 papers) and Otolaryngology and Infectious Diseases (7 papers). Sue Aspley is often cited by papers focused on Respiratory and Cough-Related Research (13 papers), Streptococcal Infections and Treatments (10 papers) and Otolaryngology and Infectious Diseases (7 papers). Sue Aspley collaborates with scholars based in United Kingdom, United States and Germany. Sue Aspley's co-authors include Simon Beckett, Stephen E. Daniels, C.A. Marsden, Michael A. Goulder, Rosamond G. Jackson, Donald R. Mehlisch, Debra A. Kendall, Keith J. Watling, C I Ragan and G Reid and has published in prestigious journals such as Biochemical Journal, Brain Research and Pain.

In The Last Decade

Sue Aspley

40 papers receiving 1.3k citations

Peers

Sue Aspley
Joseph E. Manno United States
Veijo Saano Finland
Rajan Radhakrishnan United States
H. Dix Christensen United States
Aaron H. Burstein United States
Sue Aspley
Citations per year, relative to Sue Aspley Sue Aspley (= 1×) peers Bertold Renner

Countries citing papers authored by Sue Aspley

Since Specialization
Citations

This map shows the geographic impact of Sue Aspley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Aspley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Aspley more than expected).

Fields of papers citing papers by Sue Aspley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Aspley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Aspley. The network helps show where Sue Aspley may publish in the future.

Co-authorship network of co-authors of Sue Aspley

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Aspley. A scholar is included among the top collaborators of Sue Aspley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Aspley. Sue Aspley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schachtel, Bernard, et al.. (2018). Onset of analgesia by a topically administered flurbiprofen lozenge: a randomised controlled trial using the double stopwatch method. British Journal of Pain. 12(4). 208–216. 11 indexed citations
5.
Schachtel, Bernard, et al.. (2013). The “Definite Improvement Level” (DIL) as a determinant of drug efficacy. Journal of Pain. 14(4). S5–S5. 3 indexed citations
6.
Doherty, Michael, Christopher J. Hawkey, Michael A. Goulder, et al.. (2011). A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Annals of the Rheumatic Diseases. 70(9). 1534–1541. 115 indexed citations
8.
Tanner, T., et al.. (2010). The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol. PubMed. 10(1). 10–10. 38 indexed citations
11.
Connor, Mark, Colin Church, S. Reader, et al.. (2009). Scintigraphy can be used to compare delivery of sore throat formulations. International Journal of Clinical Practice. 63(4). 606–612. 23 indexed citations
12.
Aspley, Sue, et al.. (2004). Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. British Journal of Pharmacology. 141(2). 253–262. 142 indexed citations
13.
Tao, Rui, et al.. (2002). Effects on serotonin in rat hypothalamus of d-fenfluramine, aminorex, phentermine and fluoxetine. European Journal of Pharmacology. 445(1-2). 69–81. 51 indexed citations
14.
Aspley, Sue, et al.. (2000). A highly sensitive and selective radioimmunoassay for the measurement of neurotensin. Journal of Neuroscience Methods. 100(1-2). 151–156. 4 indexed citations
15.
Graham, M. Dean, et al.. (2000). Strain differences to the effects of aversive frequency ultrasound on behaviour and brain topography of c-fos expression in the rat. Brain Research. 854(1-2). 158–164. 29 indexed citations
16.
Bennett, G.W., et al.. (2000). Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions. British Journal of Pharmacology. 131(5). 990–996. 6 indexed citations
17.
Beckett, Simon, Mark Duxon, Sue Aspley, & C.A. Marsden. (1997). Central C-Fos Expression Following 20kHz/Ultrasound Induced Defence Behaviour in the Rat. Brain Research Bulletin. 42(6). 421–426. 80 indexed citations
18.
Aspley, Sue, Susan Butler, M.R. Prow, Keith F. Martin, & D.J. Heal. (1997). D-fenfluramine-induced depletion of rat brain 5-HT is prevented by sibutramine or fluoxetine pretreatment. 1. 374. 1 indexed citations
19.
Beckett, Simon, Sue Aspley, M. Dean Graham, & C.A. Marsden. (1996). Pharmacological manipulation of ultrasound induced defence behaviour in the rat. Psychopharmacology. 127(4). 384–390. 41 indexed citations
20.
Aspley, Sue, K.C.F. Fone, C.A. Marsden, & G.W. Bennett. (1990). The effects of serotonergic lesion of else dorsal raphe nucleus on radial maze performance in rats. European Journal of Pharmacology. 183(5). 1913–1913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026